Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist
touchIN CONVERSATION for touchONCOLOGY
Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC-associated toxicities.
The experts
Prof. Giuseppe Curigliano, European Institute of Oncology and University of Milan, Italy
Dr Alison Conlin, Providence Cancer Institute, Portland, OR, USA
This…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.